The most valuable gift

When Tiina Kivelä became seriously ill, her only hope of recovery was a stem cell transplantation.

The first sign was fatigue. Somehow, it felt more severe than ordinary tiredness, and rest did not seem to make it go away. At times, however, the fatigue eased, so Tiina Kivelä from Tampere continued her life as before.

By the end of 2019, the symptoms could no longer be ignored. The fatigue had become constant. She also began to experience bouts of nausea.
“When I got my plate of food at the workplace canteen and was supposed to start eating, I simply couldn’t. The nausea was so intense. I also began to suffer from dizziness. At some point, one of my colleagues told me that I absolutely had to see a doctor,” Kivelä recalls.
Blood tests taken by an occupational health physician revealed that Kivelä’s haemoglobin level and red blood cell count were extremely low. That explained the symptoms, but what was causing them?
A brief period of monitoring showed that her blood values continued to fall. This was not a case of iron deficiency, but something far more serious. Thanks to an alert occupational health physician, Kivelä was referred for further examinations and a bone marrow biopsy.
The result came as a shock. Kivelä was diagnosed with myelodysplastic syndrome. It is a very serious blood disorder in which changes in bone marrow stem cells disrupt the production of blood cells, and it can be considered a precursor to myeloid leukaemia. Around 200 people in Finland are diagnosed with myelodysplastic syndrome each year. The disease is rare in people under the age of 50 and is more common in men than in women.
Kivelä had drawn the short straw. What made matters worse was that the disease was already at an advanced stage. Altered blast cells accounted for around ten per cent of the cells in her bone marrow.
“Ten per cent may sound like a small figure, but it isn’t. At that point, my prognosis was a life expectancy of a year and a half. My only chance of recovery was a stem cell transplantation.”

One chance

A stem cell transplantation, however, was by no means straightforward. It never is. The risks include graft-versus-host disease, infections, the adverse effects of intensive conditioning treatment and even a relapse of the disease despite treatment. Many factors affect the success of a stem cell transplantation, including the disease being treated, the patient’s age and general health, and the compatibility of the graft. On average, 50–70 per cent of adult patients are permanently cured by stem cell transplantation, with the proportion being slightly higher for myelodysplastic syndrome.
Even finding a suitable stem cell donor is far from certain. The tissue types of the donor and recipient must be a close match. Some patients never find a suitable donor, even though stem cell registries around the world contain details of millions of potential donors.
After recovering from the initial shock, Kivelä decided to leave no stone unturned.
“In a way, there were exactly two options. Either I would live for a year and a half and gradually get worse, or we would try a stem cell transplantation, which at least offered a chance for my life to continue. The risks were explained to me very carefully,” Kivelä says.
“I remember saying something to the doctor along the lines of: our daughter is about to graduate from upper secondary school and our son is about to be confirmed. I simply don’t have time to die now. So try anything. I’m in.”

An unknown saviour

For the next six months, Kivelä received cytostatic, or chemotherapy, treatment at Tampere University Hospital (TAYS), which reduced the number of blast cells in her bone marrow. At the same time, a suitable stem cell donor was sought.
“My own daughter, who had just turned 18, was tested first, but our tissue types were only a partial match. The risks would have been too high,” Kivelä says.
When no donor could be found among her close relatives, her only hope was that a suitable person could be found through the Finnish Stem Cell Registry maintained by the Blood Service or through one of its partner registries abroad. Kivelä’s stem cell treatment was taken over by the stem cell transplantation unit at Turku University Hospital (TYKS). Alongside the Helsinki hospitals of the Hospital District of Helsinki and Uusimaa (HUS), it is the only unit in Finland that performs stem cell transplantations using donor cells. Time passed.
“At some point, I began to worry when I heard nothing. Could it really be that no suitable donor could be found anywhere? Was this all my life was going to be? It was an enormous relief when I finally received word that a potentially suitable person had been found in a foreign registry.”
Under the rules of the Stem Cell Registry, the donor and the patient receiving the stem cells are only given basic information about each other. Anonymity ensures that all patients in need of help are treated equally and that no one has to carry an unreasonable burden.
“I was told that the donor was a 21-year-old man who weighed around 90 kilos. That information was relevant because it is easy to collect enough stem cells for transplantation from a young, large man,” Kivelä says.
Most importantly, in terms of the HLA gene system that regulates the human immune system, the donor differed from Kivelä by only one marker, and they also had the same blood group. The risk of severe graft-versus-host disease was low and very likely manageable with medication.

No room for error

In July 2020, Kivelä was admitted to TYKS, where preparations for the stem cell transplantation began. She received intensive chemotherapy designed to destroy the diseased stem cells in her bone marrow.
At the same time, somewhere in Central Europe, a 21-year-old man was fulfilling the promise he had made when joining the Stem Cell Registry. Before the donation, he visited a hospital to receive growth factor injections, which increased the number of stem cells in his bone marrow and made it easier to collect them.
For Kivelä, there was no turning back. The intensive chemotherapy destroyed the diseased cells, but it also destroyed the healthy ones, to the extent that any remained.
“My immune defences dropped to zero, so I spent all my time in isolation. Only family members were allowed to visit me, and even they had to wear full protective equipment. On top of that, all this happened during the worst period of the COVID-19 pandemic. It was pretty tough, both physically and mentally,” Kivelä recalls.
Thousands of kilometres away, the donation went according to plan. The collected stem cells were packed into a specially designed cooler, and a courier set off to transport the precious gift on the first available flight to Finland and Turku. There was no time to waste. The transplantation has to be carried out within 48 hours of collecting the stem cells to ensure that the cells remain viable.
At TYKS, the healthy stem cells were infused into Kivelä’s bloodstream in much the same way as a blood transfusion. As Kivelä remembers it, the infusion itself took only 25 minutes. Then came another wait, this time for the results.
Tiina Kivelä decided to tell her story so that as many people as possible could receive help.

Back among the healthy

Over the following weeks, the transplanted stem cells engrafted in Kivelä’s bone marrow. The production of new cells gradually began: first healthy white blood cells, then platelets and red blood cells. Kivelä’s blood values began to improve, and she started to feel better. The stem cell transplantation appeared to have been successful.

“I was discharged from hospital after five weeks, which is about the shortest possible time. Of course, I had to carry quite a few bags of medication home from the pharmacy, but at least I could recover at home.”

After leaving hospital, Kivelä continued taking medication to prevent graft-versus-host disease for about another six months and followed strict precautions to avoid infections.

“Because of the high risk of infection, food had to be very thoroughly cooked, and all vacuum-packed products were forbidden. I wasn’t allowed to eat any imported vegetables or fruit at all. For two or three months, I didn’t leave home because I had to avoid picking up any infections,” Kivelä says.

The stem cell treatment had a couple of other consequences that few people would think of. The chemotherapy caused Kivelä to lose her sense of smell and taste. Even her vaccine-induced immunity was wiped out along with her bone marrow.

“I basically went through the same vaccination programme as small children, although in a more intensive adult version, and then I had the COVID-19 vaccinations on top of that. My senses returned after perhaps a month and a half. It was wonderful to be able to taste coffee again!”

Kivelä estimates that life had more or less returned to normal after about a year. Her condition was, of course, monitored regularly at TAYS, and still is, but her medication had gradually been tapered off and her strength had returned. There were no lasting side effects.

In serious blood diseases such as leukaemia and myelodysplastic syndrome, a patient is generally considered cured if the disease has not recurred within five years after a stem cell transplantation using donor cells. Kivelä reached that milestone last year.

“My most recent check-up was in August, and everything was fine.”

Greetings to Turku

Kivelä has spent most of her career working in the IT sector and in project management. Volunteering is also close to her heart, and she became seriously involved in it about ten years ago.

“Perhaps I inherited it from my grandparents. They were always helping others. For a long time, I volunteered at the residential care home where my grandfather spent his final years. After he passed away, I was looking for something to do in my spare time when I came across an article in Aamulehti about the Voluntary Rescue Service, Vapepa. I decided to give it a try, and it felt like the right thing for me.”

Kivelä currently chairs the Tampere local committee of Vapepa. She is also involved in the activities of the Finnish Red Cross in Tampere.

Her serious illness forced the always energetic Kivelä to stop: the helper became the one who needed help. The experience only reinforced her sense of how important this work is.

“That is why I decided to tell my own story, so that as many people as possible could have the same chance. Once you have received a stem cell transplantation yourself, you understand what an immense gift it is, literally your whole life.”

Kivelä once again sends her thanks to all the professionals at the Stem Cell Registry, to the healthcare staff in both Tampere and Turku, and of course to the unknown young man whose stem cells made it possible for her life to continue.

“We always joke that we people from Tampere don’t have much good to say about people from Turku, but I certainly take my hat off to the staff at TYKS. Incredible professionals who never stopped encouraging me when I was beginning to lose hope. So from now on, if anyone makes fun of people from Turku, I’ll tell them: now, now, people from Turku are good people,” Kivelä laughs.

Text: Kimmo Holopainen

Photos: Leena Koskela

The article has been published in the Red Cross Magazine 4/2026.

Tiina Kivelä sent an anonymous thank-you letter to the unknown donor through the hospital.
Last modified: 19.11.2026